Emanuel Petricoin, III, Co-Director, Center for Applied Proteomics and Molecular Medicine (CAPMM), received funding for a breast cancer study.
Petricoin is collaborating with Timothy Cannon, Medical Oncologist at Inova Schar Cancer Institute.
Together, they are comparing 68 cases of RNA-amplified but DNA-normal cases to cases where both are amplified or where neither are amplified.
Petricoin received $35,700 from Inova Healthcare for this award. Funding began in Sept. 2024 and will end in March 2025.
###
ABOUT GEORGE MASON UNIVERSITY
George Mason University is Virginia’s largest public research university. Located near Washington, D.C., Mason enrolls more than 40,000 students from 130 countries and all 50 states. Mason has grown rapidly over the past half-century and is recognized for its innovation and entrepreneurship, remarkable diversity, and commitment to accessibility. In 2023, the university launched Mason Now: Power the Possible, a one-billion-dollar comprehensive campaign to support student success, research, innovation, community, and stewardship.Learn more at gmu.edu .